Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.48 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.42 |
| ▸ | FDPS | P14324 | 3/20 | 0.42 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9712731 | 1.00 | LMNA (0.62) | LMNATSHRTHRBDNM1OPRM1 | |
| SCHEMBL11330180 | 1.00 | LMNA (0.62) | LMNATSHRTHRBDNM1OPRM1 | |
| SCHEMBL8026611 | 1.00 | LMNA (0.62) | LMNATSHRTHRBDNM1OPRM1 | |
| SCHEMBL3630821 | 1.00 | LMNA (0.62) | LMNATSHRTHRBDNM1OPRM1 | |
| SCHEMBL22471933 | 1.00 | LMNA (0.62) | LMNATSHRTHRBDNM1OPRM1 | |
| SCHEMBL17822464 | 1.00 | LMNA (0.62) | LMNATSHRTHRBDNM1OPRM1 | |
| SCHEMBL2592932 | 1.00 | LMNA (0.62) | LMNATSHRTHRBDNM1OPRM1 | |
| SCHEMBL9304805 | 1.00 | LMNA (0.62) | LMNATSHRTHRBDNM1OPRM1 | |
| SCHEMBL3634317 | 1.00 | LMNA (0.62) | LMNATSHRTHRBDNM1OPRM1 | |
| SCHEMBL5500151 | 1.00 | LMNA (0.62) | LMNATSHRTHRBDNM1OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122030497-A | Fermentation method for cooperatively treating ganoderma lucidum by bacterial enzymes and application of fermentation method in pet food | 杭州半边野兽科技有限公司 | 2026-05-15 | — | — | CN | disclosed |
| EP-3004072-A1 | METHODS FOR PRODUCING FUELS, GASOLINE ADDITIVES, AND LUBRICANTS | The Regents of The University of California (US) | 2016-04-13 | — | — | EP | disclosed |
| WO-2014197514-A1 | METHODS FOR PRODUCING FUELS, GASOLINE ADDITIVES, AND LUBRICANTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-12-11 | — | — | WO | disclosed |
| US-8557565-B2 | Degradation of polycyclic aromatic hydrocarbons to render them available for biodegradation | WAVREK DAVID (US) | 2013-10-15 | — | — | US | disclosed |
| US-8298814-B1 | Degradation of polycyclic aromatic hydrocarbons | Wavrek, David A. (US) | 2012-10-30 | — | — | US | disclosed |
| US-20080242875-A1 | DEGRADATION OF POLYCYCLIC AROMATIC HYDROCARBONS TO RENDER THEM AVAILABLE FOR BIODEGRADATION | HONG P K ANDY | 2008-10-02 | — | — | US | disclosed |
| EP-1230400-B1 | DEGRADATION OF POLYCYCLIC AROMATIC HYDROCARBONS | UNIV UTAH RES FOUND (US) | 2008-09-24 | — | — | EP | disclosed |
| EP-1230400-A1 | DEGRADATION OF POLYCYCLIC AROMATIC HYDROCARBONS | University of Utah Research Foundation (US) | 2002-08-14 | — | — | EP | disclosed |
| WO-2001032936-A1 | DEGRADATION OF POLYCYCLIC AROMATIC HYDROCARBONS | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2001-05-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080242875-A1 | DEGRADATION OF POLYCYCLIC AROMATIC HYDROCARBONS TO RENDER THEM AVAILABLE FOR BIODEGRADATION | PAH, AHR, TDO2 | LMNA 1818/4885TSHR 2267/4885THRB 2054/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.